The only curative therapy for MDS is allogeneic bone marrow transplantation. Outpatient Services Available Patients with MDS who desire consultation services or second opinions are seen in the Myeloid Disorders Clinic. Inpatient Services Available Patients with MDS undergoing intensive chemotherapy are treated on a 21 bed unit specialized for the aggressive treatment of patients with hematologic malignancies. The nursing staff is highly trained in the care of patients with hematologic malignancies and in critical care. The unit is capable of providing conventional and intensive care.
All rooms are private with special air-filtering to decrease the risk of infections.
Patients undergoing bone marrow transplantation are hospitalized on a separate specialty unit or are treated in our new IPOP unit. Some patients on research protocols are hospitalized in the General Clinical Research Center. New Therapy Highlight Sodium Phenylbutyrate is a small molecule which has been used for the treatment of childhood metabolic disorders and adult sickle cell anemia. It is very well-tolerated in those diseases. In the laboratory, Sodium Phenylbutyrate causes some leukemic cell lines to mature into normal blood cells.